Literature DB >> 26483388

Surviving protein quality control catastrophes--from cells to organisms.

Kim Schneider1, Anne Bertolotti2.   

Abstract

Organisms have evolved mechanisms to cope with and adapt to unexpected challenges and harsh conditions. Unfolded or misfolded proteins represent a threat for cells and organisms, and the deposition of misfolded proteins is a defining feature of many age-related human diseases, including the increasingly prevalent neurodegenerative diseases. These protein misfolding diseases are devastating and currently cannot be cured, but are hopefully not incurable. In fact, the aggregation-prone and potentially harmful proteins at the origins of protein misfolding diseases are expressed throughout life, whereas the diseases are late onset. This reveals that cells and organisms are normally resilient to disease-causing proteins and survive the threat of misfolded proteins up to a point. This Commentary will outline the limits of the cellular resilience to protein misfolding, and discuss the possibility of pushing these limits to help cells and organisms to survive the threat of misfolding proteins and to avoid protein quality control catastrophes.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Protein quality control; Proteostasis; Stress responses

Mesh:

Substances:

Year:  2015        PMID: 26483388     DOI: 10.1242/jcs.173047

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

Review 1.  Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain.

Authors:  Antonio Currais; Wolfgang Fischer; Pamela Maher; David Schubert
Journal:  FASEB J       Date:  2017-01       Impact factor: 5.191

2.  The antibiotic robenidine exhibits guanabenz-like cytoprotective properties by a mechanism independent of protein phosphatase PP1:PPP1R15A.

Authors:  Zander Claes; Marloes Jonkhout; Ana Crespillo-Casado; Mathieu Bollen
Journal:  J Biol Chem       Date:  2019-07-23       Impact factor: 5.157

Review 3.  Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy.

Authors:  Caroline Sibilla; Anne Bertolotti
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

4.  Widespread remodeling of proteome solubility in response to different protein homeostasis stresses.

Authors:  Xiaojing Sui; Douglas E V Pires; Angelique R Ormsby; Dezerae Cox; Shuai Nie; Giulia Vecchi; Michele Vendruscolo; David B Ascher; Gavin E Reid; Danny M Hatters
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-21       Impact factor: 11.205

5.  Pervasive convergent evolution and extreme phenotypes define chaperone requirements of protein homeostasis.

Authors:  Yasmine Draceni; Sebastian Pechmann
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-16       Impact factor: 11.205

Review 6.  Regulating Secretory Proteostasis through the Unfolded Protein Response: From Function to Therapy.

Authors:  Lars Plate; R Luke Wiseman
Journal:  Trends Cell Biol       Date:  2017-06-21       Impact factor: 20.808

Review 7.  Mechanisms and functions of ribosome-associated protein quality control.

Authors:  Claudio A P Joazeiro
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

8.  Decoding the selectivity of eIF2α holophosphatases and PPP1R15A inhibitors.

Authors:  Marta Carrara; Anna Sigurdardottir; Anne Bertolotti
Journal:  Nat Struct Mol Biol       Date:  2017-07-31       Impact factor: 15.369

9.  An inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response.

Authors:  Aude De Gassart; Bojan Bujisic; Léa Zaffalon; Laurent A Decosterd; Antonia Di Micco; Gianluca Frera; Rémy Tallant; Fabio Martinon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-29       Impact factor: 11.205

Review 10.  Revealing functional insights into ER proteostasis through proteomics and interactomics.

Authors:  Madison T Wright; Lars Plate
Journal:  Exp Cell Res       Date:  2020-12-08       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.